Tag Archives: Robert Temple

Temple 'Horrified' by Caronia Decision

If people can promote drugs for uses that lack supporting evidence, it would turn back the clock to the pre-1962 world of medicine where there wasn’t any research or data on what medicines worked and what was harmful, says Robert Temple, deputy director for clinical science at FDA’s Center for Drug Evaluation and Research (CDER).
Posted in compliance, FDA, Marketing, Sales | Also tagged , , , , | 2 Comments
  • Categories

  • Meta